Drug factory · FDA FEI 3002807359

Jetpharma SA

Via Sottobisio 42ac, Balerna, Switzerland

Switzerland: 1

No problems found at FDA's last inspection, Jun 23, 2023.

No Action Indicated: inspectors found no objectionable conditions.

6 drug inspections on record since 2011: 3 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
BosentanMills it Actelion Pharmaceuticals US, Inc. 66215-101, 66215-102, 66215-232
MacitentanMills it Actelion Pharmaceuticals US, Inc. 66215-501
Macitentan and TadalafilMakes the active ingredient and mills it Actelion Pharmaceuticals US, Inc. 66215-812, 66215-814
MaribavirMills it Takeda Pharmaceuticals America, Inc. 64764-800
PonesimodMills it Janssen Pharmaceuticals, Inc. 50458-707, 50458-720
TiratricolMills it Rare Thyroid Therapeutics International AB 87216-0100

FDA inspection history

EndedResultProgramProblems noted
Jun 23, 2023No problems foundDrug Quality Assurance—
Feb 7, 2020Problems found, fixed voluntarilyDrug Quality Assurance2
Dec 1, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 29, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
May 8, 2013No problems foundDrug Quality Assurance—
Feb 16, 2011No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Feb 7, 2020 inspection

Registered with FDA for: api manufacture; particle size reduction.